The global tally for the coronavirus-borne illness rose above 133 million on Thursday, according to data aggregated by Johns Hopkins University, while the death toll rose above 2.88 million. The U.S. continues to lead the world by cases, at 30.9 million, or about a quarter of the global tally, and fatalities, at 559,117. The U.S. added at least 73,200 new cases on Wednesday, according to a New York Times tracker, and at least 2,564 people died. The U.S. has averaged 65,556 cases a day for the last week, up 14% from the average two weeks ago, as cases continue to rise despite the vaccination program, a trend experts say is due to states reopening and dropping restrictions on movement and overall pandemic fatigue. The vaccine developed by AstraZeneca PLC
faced fresh challenges Thursday, whenSpain and Italy said they would limit its use to people over 60, a day after the European Medicines Agency (EMA) said it had found a possible link between the vaccine and very rare cases of blood clotting issues in adults. The U.K., which has been using that vaccine widely, said that people under 30 should be offered alternative shots, if possible. The AstraZeneca vaccine has not been authorized in the U.S. although it is requesting authorization from the FDA.
Outside of the U.S., Brazil is second globally in cases at 13.2 million and also second with a death toll of 340,776. India is third worldwide in cases with 12.9 million and fourth in deaths at 166,862. Mexico is third by deaths at 205,598 and 14th highest by cases at 2.3 million. The U.K. has 4.4 million cases and 127,171 deaths, the highest in Europe and fifth highest in the world.